We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.1B
AUM Growth
+$5.57B
(+17%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$2.28B |
| 2 |
Otis Worldwide
OTIS
|
+$193M |
| 3 |
Burlington
BURL
|
+$191M |
| 4 |
AbbVie
ABBV
|
+$178M |
| 5 |
Wayfair
W
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Lockheed Martin
LMT
|
+$339M |
| 3 |
Johnson & Johnson
JNJ
|
+$262M |
| 4 |
Pfizer
PFE
|
+$167M |
| 5 |
Target
TGT
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 11.33% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPAQ.WS
676
DELISTED
Spartan Energy Acquisition Corp. Warrants, each whole warrant exercisable for one Class A common sto
SPAQ.WS
| $2.27M | 0.01% |
1,259,000
-325,000
| -21% | -$212K |
|
677
Axalta
AXTA
$8.05B
| $2.25M | 0.01% |
+100,000
| New | +$2.05M |
|
678
Dentsply Sirona
XRAY
$2.86B
| $2.25M | 0.01% |
51,100
-4,200
| -8% | -$178K |
|
679
Coherus Oncology
CHRS
$228M
| $2.23M | 0.01% |
125,000
-25,000
| -17% | -$423K |
|
680
TechnipFMC
FTI
$27.5B
| $2.15M | 0.01% |
+422,688
| New | +$2.46M |
|
681
Peabody Energy
BTU
$2.72B
| $2.14M | 0.01% |
+742,981
| New | +$2.45M |
|
682
Gran Tierra Energy
GTE
$242M
| $2.08M | 0.01% |
600,000
+41,929
| +8% | +$136K |
|
683
Element Solutions
ESI
$9.48B
| $2.05M | 0.01% |
188,618
| – | – |
|
|
KYNB
684
Kyntra Bio
KYNB
$28M
| $2.03M | 0.01% |
2,000
| – | – |
|
685
Expro Ltd
XPRO
$1.88B
| $1.96M | 0.01% |
146,808
| – | – |
|
|
SHLL.WS
686
DELISTED
Tortoise Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common
SHLL.WS
| $1.89M | ﹤0.01% |
175,000
-837,500
| -83% | -$1.48M |
|
687
JetBlue
JBLU
$2.42B
| $1.85M | ﹤0.01% |
169,600
+120,000
| +242% | +$1.18M |
|
688
Viatris
VTRS
$20.6B
| $1.84M | ﹤0.01% |
114,711
-1,722,409
| -94% | -$27.9M |
|
689
AAR Corp
AIR
$5.96B
| $1.78M | ﹤0.01% |
85,995
-46,290
| -35% | -$896K |
|
690
Cooper Companies
COO
$14.6B
| $1.75M | ﹤0.01% |
24,732
-198,800
| -89% | -$14.7M |
|
691
Kinetik
KNTK
$3.58B
| $1.73M | ﹤0.01% |
272,410
+100,000
| +58% | +$683K |
|
692
News Corp Class B
NWS
$17.7B
| $1.67M | ﹤0.01% |
139,938
+7,507
| +6% | +$81.3K |
|
693
Alpha Metallurgical Resources
AMR
$1.78B
| $1.6M | ﹤0.01% |
525,000
+77,453
| +17% | +$278K |
|
694
Arq
ARQ
$88.9M
| $1.46M | ﹤0.01% |
+300,000
| New | +$1.73M |
|
|
DMS
695
DELISTED
Digital Media Solutions, Inc.
DMS
| $1.45M | ﹤0.01% |
9,300
| – | – |
|
696
Coty
COTY
$2.56B
| $1.44M | ﹤0.01% |
322,944
-7,400
| -2% | -$35.9K |
|
|
EXTN
697
DELISTED
Exterran Corporation
EXTN
| $1.4M | ﹤0.01% |
+260,000
| New | +$1.47M |
|
698
HUB Group
HUBG
$2.92B
| $1.32M | ﹤0.01% |
55,030
-55,600
| -50% | -$1.28M |
|
699
Camden Property Trust
CPT
$11B
| $1.26M | ﹤0.01% |
13,781
-135,034
| -91% | -$11.9M |
|
700
Waters Corp
WAT
$38.9B
| $1.2M | ﹤0.01% |
6,643
-15,991
| -71% | -$3.02M |
|
Similar funds
Adage Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.
- Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
- Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
- Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
- Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
- Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
- Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
- Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.
Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.